Related Experiment Video
Updated: Aug 20, 2026
Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Use of intermediate cardiovascular endpoints in intervention studies: not as easy as it seems?
Insights
Smoking cessation did not significantly alter carotid intima-media thickness (CIMT) or arterial stiffness progression in a two-year study. Further investigation is needed to validate these unexpected cardiovascular risk findings.
Area of Science:
- Cardiovascular Health
- Smoking Cessation Research
- Vascular Biology
Background:
- Investigated the impact of smoking cessation on cardiovascular risk markers.
- Assessed changes in carotid intima-media thickness (CIMT) and arterial stiffness.
- Compared outcomes between quitters, persistent smokers, and never-smokers.
Discussion:
- The study found no significant differences in CIMT or arterial stiffness progression between groups.
- This unexpected finding raises questions about the study's design and analytical methods.
- Potential limitations include sample size and the chosen study endpoint.
Key Insights:
- Two years of smoking cessation did not show measurable benefits in CIMT or arterial stiffness.
- The study highlights the complexity of demonstrating short-term vascular benefits of quitting smoking.
- Results challenge conventional understanding of immediate cardiovascular risk reduction post-cessation.
Outlook:
- Further research with robust methodologies is required to confirm these findings.
- Exploring alternative biomarkers for cardiovascular risk in smokers is recommended.
- Investigating long-term effects beyond two years may reveal different outcomes.
Abstract:
In the current issue of the Journal, Van den Berkmortel and coworkers' report on the effect of smoking cessation on cardiovascular risk reduction, as estimated by assessment of progression of carotid intima-media thickness (CIMT) and arterial stiffness. Much to the authors' surprise, their nonrandomised study among 33 subjects who stopped smoking for at least two years, 55 persistent smokers and 50 never-smokers showed no difference in rate of change in CIMT or arterial stiffness across the groups after two years of intervention. The intriguing question of the paper is whether the finding is true or may be attributed to potential flaws of the study, focussing on design and analytical procedures, the choice of the endpoint and the power of the study.
